Linerixibat, Purity ≥98%

Synonym: 1345982-69-5; GSK 2330672; GSK-2330672; 3-[[(3R,5R)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-1λ6,4-benzothiazepin-8-yl]methylamino]pentanedioic acid

MDL: MFCD28386358
CAS Number: 1345982-69-5
Compound CID: 53492727

Product Size

5 mg; 10 mg; 20 mg; 50 mg

Price

Datasheet

MSDS

Properties

Description

Linerixibat is a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor. The molecular weight of the compound is 546.67, and its molecular formula is C₂₈H₃₈N₂O₇S.

Molecular Weight

546.67

Molecular Formula

C₂₈H₃₈N₂O₇S

Form

Lyophilized powder

Purity

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

Linerixibat can be studied extensively for its potential therapeutic applications in the treatment of irritable bowel syndrome with constipation (IBS-C) and other gastrointestinal disorders.